Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Burrill & Company was a San Francisco-based financial firm specializing in biotechnology and life sciences investing. It managed funds that invested in early-stage companies in biotechnology, life sciences, and healthcare.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Energy Tech1
Q&A
- What is Burrill & Company's most notable exit?
- Burrill & Company had a notable exit in June 2014 with the acquisition of Virdia by Stora Enso for $33M.
- Which sector does Burrill & Company primarily focus on for investments?
- Burrill & Company shows a concentration in the Energy Tech sector, with all of its portfolio companies and exits being in this area.
- Can you name a key company in Burrill & Company's portfolio?
- A key company in Burrill & Company's portfolio was Virdia, which focused on cellulosic sugars and lignin for renewable chemicals production.
- What was the total amount raised by Virdia, a former portfolio company of Burrill & Company?
- Virdia, a former portfolio company, raised $36.4M before its acquisition.
- When did Burrill & Company make its most recent investment according to available data?
- Burrill & Company's most recent recorded investment activity occurred in March 2012.
- What is the typical investment range for Burrill & Company?
- Burrill & Company typically invests between $5.5M and $20M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1994 |
|---|
Radar intelligence
Patents
| EPO | 79 |
|---|